0001683168-24-002285.txt : 20240410
0001683168-24-002285.hdr.sgml : 20240410
20240410215115
ACCESSION NUMBER: 0001683168-24-002285
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240408
FILED AS OF DATE: 20240410
DATE AS OF CHANGE: 20240410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cockroft Bettina M.
CENTRAL INDEX KEY: 0001900452
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 24837005
MAIL ADDRESS:
STREET 1: C/O ANNEXON, INC.
STREET 2: 180 KIMBALL WAY, SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
ownership.xml
X0508
4
2024-04-08
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001900452
Cockroft Bettina M.
C/O CNS PHARMACEUTICALS, INC
100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
1
0
0
0
0
Option to purchase common stock
0.2586
2024-04-08
4
A
0
17500
A
2034-04-08
Common Stock
17500
35574
D
Restricted Stock Units
2024-04-08
4
A
0
17500
A
Common Stock
17500
53074
D
The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
The awards were issued in connection with the reporting person's Board of Director services to the Company.
Each restricted stock unit represents a contingent right to receive one share of the Company common stock.
/s/ Christopher Downs, Attorney-in-fact
2024-04-10